Tissue and serum borne tumor markers of oral squamous cell carcinoma: Present and forthcoming therapeutic roles

European Journal of Plastic Surgery

Volumn 25, Issue 5, 2002, Pages 235-242

  Nagler, R M ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Field cancerization; Oral squamous cell carcinoma; p53; Tumor markers

Indexed keywords

BLOOD GROUP ANTIGEN; CARBOHYDRATE; CARCINOGEN; CELL SURFACE MARKER; CYTOKERATIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P53; RIBOSOME RNA; TISSUE POLYPEPTIDE ANTIGEN; TRANSFORMING GROWTH FACTOR; TUMOR MARKER;

ANEUPLOIDY; ANTIGEN EXPRESSION; BLOOD GROUP ABO SYSTEM; CANCER DIAGNOSIS; CANCER RISK; CANCER THERAPY; CARCINOGENESIS; CARCINOGENICITY; CELL DEATH; CELL DIFFERENTIATION; CELL DIVISION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL TRANSFORMATION; CHROMOSOME NOR; DNA CONTENT; DNA REPAIR; DNA STRAND BREAKAGE; GENE EXPRESSION; GENE INACTIVATION; GENE LOCUS; GENE MUTATION; GENOMIC INSTABILITY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; METASTASIS; MOUTH CARCINOMA; NATURAL KILLER CELL; NICK END LABELING; NONHUMAN; ONCOGENE; ONCOGENE C MYC; ONCOGENE H RAS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTO ONCOGENE; REVIEW; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TUMOR IMMUNITY; TUMOR REGRESSION; TUMOR SUPPRESSOR GENE; WOUND HEALING;

EID: 0038274198     PISSN: 0930343X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00238-002-0406-4     Document Type: Review

References (99)

1. Ahomadegbe JC, Barrois M, Fogel S (1995) High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions. Oncogene 10:1217
2. Balaram P, Mennattoor G (1996) Immunology of oral cancer - a review. Singapore Dent J 21:36
3. Bànkfalvi A, Piffkò J (2000) Prognostic and predictive factors in oral cancer: the role of the invasive tumour front. J Oral Pathol Med 29:2291
4. Bialy H (1998) Aneuploidy and cancer: vintage wine in a new bottle? Nat Biotechnol 16:137
5. Boyle JO, Mao L, Brennan JA, Koch WM, Eisele DW, Saunders JR (1994) Gene mutations in saliva as molecular markers for head and neck squamous cell carcinomas. Am J Surg 168:429
6. Brennan JA, Mao L, Hruban RH (1995) Molecular assessment of histopathological staging in squamous cell carcinoma of the head and neck. N Engl J Med 332:429
7. Bryne M (1991) Prognostic value of various molecular and cellular features in oral squamous cell carcinomas. A review. J Oral Pathol Med 20:413
8. Bryne M, Reibel J, Mandel U, Dabelsteen E (1991) Reproducibility of two malignancy grading systems with reportedly prognostic value for oral cancer patients. J Oral Pathol Med 20:413
9. Bryne M, Reibel J, Mandel U, Dabelsteen E (1991) Expression of mucin type carbohydrates may supplement histologic diagnosis in oral premalignant lesions. J Oral Pathol Med 20:120
10. Burkhardt A (1996) Oncogenes and growth factor receptors as diagnostic and prognostic markers in precancers and cancers of the oral mucosa. Curr Top Pathol 90:223
11. Chandran GJ, Balaram P, Kannan S, Pillai R, Nalinakumari KR, Nair NK (1994) Immunohistochemical localization of epidermal growth factor and its receptor in normal, premalignant and malignant oral mucosa. Int J Oncol 4:503
12. Chang F, Syrjanen S, Kurvinen K, Syrjanen K (1993) The p53 tumor suppressor gene as a common cellular target in human carcinogenesis. Am J Gastroenterol 88:174
13. Chiesa F, Tradati N, Sala L (1990) Follow-up of oral leukoplakia after carbon dioide laser surgery. Arch Otolaryngol Head Neck Surg 116:177
14. Coltera MD, Zarbo RJ, Sakr WA, Gown AM (1992) Markers for dysplasia of the upper aero-digestive tract; suprabasal expression of PCNA, p53 and CK 19 in alcohol fixed embedded tissue. Am J Pathol 141:817
15. Dabelsteen E, Clausen H, Mandel U (1991) Aberrant glycosylation in oral malignant and premalignant lesions. J Oral Pathol Med 20:361
16. Dabelsteen E, Clausen H, Mandel U (1992) Carbohydrate changes in squamous cell carcinoma. APMIS Suppl 27 100:130
17. Eisbruch A, Blick M, Lee JS, Sacks PG, Gutterman J (1987) Analysis of the epidermal growth factor receptor gene in fresh human head and neck cancers. Cancer Res 47:3603
18. Epstein JB, Scully C (1997) Assessing the patient as risk for oral squamous cell carcinoma. Spec Care Dentist 17:120
19. Field JK, Spandidos DA, Malliri A, Gosney JR, Ylagnisis M, Stell PM (1991) Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck. Br J Cancer 64:573
20. Forastiere A, Kock W, Trotti A, Sidransky D (2001) Head and neck cancer. N Engl J Med 345:1890
21. Gallo O, Bianchi S, Giovannucci-Uzzielli ML, Santoro R, Lenzi S, Salimbeni C, Abruzzese M, Alajamo E (1995) p53 oncoprotein expression correlates with mutagen-induced chromosome fragility in head and neck cancer patients with multiple malignancies. Br J Cancer 71:1008
22. Gapany M, Pavelic ZP, Gapany SR, Pavelic L, Li YQ, Craven JM, Jones H, Biddinger P, Stambrook PJ, Cluckman JL (1993) Relationship between immunohistochemically detectable p53 protein and prognostic factors in head and neck tumors. Cancer Detect Prev 17:379
23. Giaccia AJ, Kastan MB (1998) The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev 12:2973
24. Gluckman JL, Stambrook PJ, Pavelic ZP (1994) Prognostic significance of p53 protein accumulation in early stage T1 oral cavity cancer. Eur J Cancer B Oral Oncol 30:281
25. Grandis JR, Tweardy DJ (1993) Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res 53:3579
26. Hakomori S (1989) Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv Cancer Res 52:257
27. Hemmer J, Kreidler J (1990) Flow cytometric DNA ploidy analysis of squamous cell carcinoma of the oral cavity: comparison with clinical staging and histologic grading. Cancer 60:317
28. Hirsch SM, DuCanto J, Caldarelli DD, Hutchinson JC, Coon JS (1992) Nucleolar organizer regions in squamous cell carcinoma of the head and neck. Laryngoscope 102:39
29. Högmo A, Munck-Wikland E, Kuylenstrierna R, Lindholm J, Auer G (1994) Nuclear DNA content and p53 immunostaining in oral squamous cell carcinoma - an analysis of a consecutive 10-year material. Int J Oncol 5:519
30. Huang MF, Chang YC, Liao PS, Huang TH, Tsay CH, Chou MY (1999) Loss of heterozygosity of p53 gene of oral cancer detected by exfoliative cytology. Oral Oncol 35:296
31. Ishitoya J, Toriyama M, Oguchi N, Kitamura K, Ohshima M, Asano K, Yamamoto T (1989) Gene amplification and overexpression of EGF receptor in squamous cell carcinomas of the head and neck. Br J Cancer 59:559
32. Iversen OH (1985) What is new in endogenous growth stimulators and inhibitors (chalones). Pathol Res Pract 180:77
33. Jones AS, Roland NJ, Caslin AW, Cooke TG, Cooke LD, Forester G (1994) A comparison of cellular proliferation markers in squamous cell carcinoma of the head and neck. J Laryngol Otol 108:859
34. Joypaul BV, Newman EL, Hopwood D (1993) Expression of p53 protein in normal, dysplastic and malignant gastric mucosa: an immunohistological study. J Pathol 170:279
35. Kellof GJ, Malone WF, Beone CW, Segman CC, Fay JR (1990) Progressin applied chemoprevention research. Semin Oncol 17:438
36. Kim J, Shin DM (1997) Biomarkers of squamous cell carcinoma of the head and neck. Histol Histopathol 12:205
37. Kowalski LP, Medina JE (1998) Modal metastases: predictive factors. Otolaryngol Clin North Am 31:621
38. Kropveld A, Rozemuller EH, Leppers FGJ (1999) Sequencing analysis of RNA and DNA of exons 1 through 11 shows p53 gene alterations to be present in almost 100% of head and neck squamous cell carcinomas. Lab Invest 79:347
39. Kuratsu S, Aozasa K, Myoui A, Tsujimoto M, Ueda T, Uchida A (1991) Prognostic significance of agyrophilic nucleolar organizer staining in soft-tissue sarcomas. Int J Cancer 48:211
40. Lane DP (1992) p53, guardian of the genome. Nature 358:15
41. Lane DP, Benchimol S (1990) p53: oncogene or anti-oncogene. Genes Dev 4:1
42. Lengauer C, Kinzier KW, Vogelstein B (1998) Genetic instabilities in human cancers. Nature 396:643
43. Levine AJ (1997) p53, the cellular gatekeeper for growth and division. Cell 88:323
44. Levine AJ, Momand J, Finlay CA (1991) the p53 tumor suppressor gene. Nature 351:453
45. Levine AJ, Perry ME, Chang A (1994) The 1993 Walter Hubert Lecture: the role of the p53 tumor-suppressor gene in tumorigenesis. Br J Cancer 69:409
46. Libermann DA, Hoffman B, Steinman RA (1995) Molecular controls of growth arrest and apoptosis: p53 dependent and independent pathways. Oncogene 11:199
47. Lippman SM, Hong WK (2001) Molecular markers of the risk of oral cancer. N Engl J Med 344:1323
48. Lippman SM, Peters EJ, Wargovich MJ (1990) Bronchial micronuclei as a marker of an early stage of carcinogenesis in the tracheobronchial epithelium. Int J Cancer 45:811
49. Lippman SM, Hong WK (1992) Differentiation therapy for head and neck cancer. In: Snow G, Clark R (eds) Multimodality therapy for head and neck cancer. Springer, Berlin Heidelberg New York, pp 160-181
50. Lowe S, Schmitt EM, Smith SW, Osborne BA, Jacks T (1993) p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362:847
51. Macluskey M, Ogden GR (2000) An overview of the prevention of oral cancer and diagnostic markers of malignant change. II. Markers of value in tumor diagnosis. Dent Update 27:148
52. Malusardi G, Oldini C, Leopardi O (1992) The quantitative study of nucleolar organizers (AgNOR) in the diagnosis of laryngeal dysplasias and in the assessment of the prognosis in invasive carcinoma. Acta Otorhinolaryngol Ital 12:3
53. Mandel U, Petersen OW, Sørensen H, Vedtofte P, Hakomori S, Clausen H, Dabelsteen E (1991) Simple mucin-like carbohydrates in oral stratified squamous and salivary gland epithelia. J Invest Dermatol 97:713
54. Merritt DW, Weissler MC, Turk BF, Gilmer TM (1990) Oncogene amplification in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 116:1394
55. Nagler RM, Barak M, Peled M, Ben-Aryeh H, Filatov M, Laufer D (1999) Early diagnosis and treatment monitoring roles of tumor markers Cyfra 21-1 and TPS in oral squamous cell carcinoma. Cancer 85:1018
56. Nagler RM, Laufer D, Kerner H (2001) Squamous cell carcinoma of the tongue: the prevalence and prognostic roles of p53, Bcl-2, c-erbB2 and apoptotic rate as related to clinical and pathological characteristics in a retrospective study. Cancer Lett (in press)
57. Nair U, Bartsch H (2001) Metabolic polymorphisms as susceptibility markers for lung and oral cavity cancer. IARC Sci Publ 154:271
58. Nylander K, Dabelsteen E, Hall PA (2000) The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck. J Oral Pathol 9:413
59. Nylander K, Stenling R, Gustafsson H, Zackrisson B, Roos G (1995) p53 expression and cell proliferation in squamous cell carcinomas of the head and neck. Cancer 75:87
60. Ogden GR, Kiddie RA, Lunny DP, Land DP (1992) Assessment of p53 protein in normal, benign and malignant oral mucosa. J Pathol 166:389
61. Oren M (1992) p53: the ultimate tumor suppressor gene? FASEB J 6:3169
62. Ozanne B, Richards CS, Hendler F, Burns D, Gutterson B (1986) Overexpression of the EGF receptor is a hallmark of squamous cell carcinomas. J Pathol 149:9
63. Partridge M, Gullick WJ, Langdon JD, Sherriff M (1988) Expression of epidermal growth factor receptor on oral squamous cell carcinoma. Br J Oral Maxillofac Surg 26:381
64. Piffkò J, Bànkfalvi A, Tory K (1998) Molecular assessment of p53 abnormalities at the invasive front of oral squamous cell carcinoma. Head Neck 20:8
65. Pillai MR, Ravi D, Nair MK (1997) Chemoprevention in oral cancer: the need for effective biological monitoring. Singapore Dent J 22:6
66. Polyak A, Xia Y, Zweier JL, Kinzler KW, Vogelstein B (1997) A model for p53-induced apoptosis. Nature 389:300
67. Prives C, Hall PA (1999) The p53 pathway. J Pathol 187:112
68. Raybaud-Diogène H, Tétu B, Morency R, Fortin A, Monteil RA (1996) p53 overexpression in head and neck squamous cell carcinoma: review of the literature. Eur J Cancer B Oral Oncol 32:143
69. Regezi JA, Zarbo RJ, Regev E, Pisanty S, Silverman S, Gazit D (1995) p53 protein expression in sequential biopsies of oral dysplasias and in situ carcinomas. J Oral Pathol Med 24:18
70. Saito T, Notani K, Miura H (1991) DNA analysis of oral leukoplakias by flow cytometry. Int J Oral Maxillofac Surg 20:259
71. Saunders WS, Shuster M, Huang X (2000) Chromosomal instability and cytoskeletal defects in oral cancer cells. Proc Natl Acad Sci USA 97:303
72. Schepman KP, van der Meij EH, Smeele LF, van der Waal I (1996) Prevalence study on oral white lesions with special reference to a new definition of oral leukoplakia. Eur J Cancer B Oral Oncol 32:416
73. Schmale H, Bamberger C (1997) A novel protein with strong homology to the tumor suppressor p53. Oncogene 15:1363
74. Schwartz JL (2000) Biomarkers and molecular epidemiology and chemoprevention of oral carcinogenesis. Crit Rev Oral Biol Med 11:92
75. Scully C, Burkhardt A (1993) Tissue markers of potentially malignant oral epithelial lesions. J Oral Pathol Med 22:246
76. Scully C, Field JK (1997) Genetic aberrations in squamous cell carcinoma of the head and neck (SCCHN), with reference to oral carcinoma. Int J Oncol 10:5
77. Scully C, Field JK, Tanzawa H (2000) Genetic aberrations in oral or head and neck squamous cell carcinoma 3: clinicopathological applications. Oral Oncol 36:404
78. Sell S (1990) Cancer-associated carbohydrates identified by monoclonal antibodies. Hum Pathol 21:1003
79. Sen S (2000) Aneuploidy and cancer. Curr Opin Oncol 12:82
80. Shin DM, Hittleman WN, Hong WK (1994) Biomarkers in upper aerodigestive tract tumorigenesis: a review. Cancer Epidemiol Biomarkers Prev 3:697
81. Shin DM, Kim J, Ro JY, Hittleman J, Roth JA, Hong WK, Hittleman WN (1994) Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis. Cancer Res 54:321
82. Shin DM, Ro JY, Hong WK, Hittleman WK (1994) Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis. Cancer Res 54:3153
83. Shin DM, Ro JY, Shah T, Hong WK, Hittleman WN (1994) p53 expression and genetic instability in head and neck multistep tumorigenesis. Proc Am Assoc Cancer Res 35:38
84. Shin DM, Lee JS, Lippman SM, Lee JJ, Tu ZN, Choi G, Heyne K Shin HJC, Ro JY, Goepfert H, Hong WK, Hittelman WN (1996) p53 expression: predicting recurrence and second primary tumors in head and neck squamous cell carcinoma. J Natl Cancer Inst 88:519
85. Shirasuna K, Hayashido Y, Sugiyama M, Yoshioka H, Matsuya T (1991) Immunohistochemical localization of epidermal growth factor (EGF) and EGF receptors in human oral mucosa and its malignancy. Virchows Arch A Pathol Anat 418:349
86. Slootweg PJ (1996) Suppressor protein p53 and its occurrence in oral tumours. Curr Top Pathol 90:179
87. Smets LA, van Beek WP (1984) Carbohydrates of the tumor cell surface. Biochim Biophys Acta 738:237
88. Somers KD, Merrick MA, Lopez ME, Incofnito LS, Schechter GL, Casey G (1992) Frequent p53 mutations in head and neck cancer. Cancer Res 52:5997
89. Tralongo V, Rodolica V, Lucianai A, Marra G, Daniele E (1999) Prognostic factors in oral squamous cell carcinoma. A review of the literature. Anticancer Res 19:3505
90. Van Waes C, Carey TE (1992) Overexpression of the A9 antigen/ á6â4 integrin in heal and neck cancer. Otolaryngol Clin North Am 25:117
91. Voravud N (1996) Chemoprevention of head and neck cancer. J Med Assoc Thai 79:185
92. Vries N de, van Zandwijk N, Pastoring U (1999) Chemoprevention of head and neck and lung (pre) cancer. Rec Res Cancer Res 151:13
93. Warnakulasuriya KAAS, Johnson NW (1993) Nucleolar organizer region (NOR) distribution as a diagnostic marker in oral keratoses, dysplasia and squamous cell carcinomas. J Oral Pathol Med 22:77
94. Welkoborsky HJ, Hinni M, Dienes HP, Mann WJ (1995) Potential early markers of carcinogenesis in the mucosa of the head and neck using exfoliative cytology. Ann Otol Rhinol Laryngol 104:503
95. Xie X, Clausen OPF, Sudbö J, Boysen M (1997) Diagnostic and prognostic value of nucleolar organizer regions in normal epithelium, dysplasia and squamous cell carcinoma of the oral cavity. Cancer 79:2200
96. Xie X, Stenersen TC, Clausen OPF, Boysen (1997) Nucleolar organizer regions and prognosis in glottic squamous cell carcinoma. Head Neck 12:20
97. Xie X, Clausen OP, De Angelis P, Boysen M (1999) The prognostic value of spontaneous apoptosis, Bax, Bcl-2 and p53 in oral squamous cell carcinoma of the tongue. Cancer 86:913
98. Yao L, Iwai M, Furuta I (1999) Correlations of bcl-2 and p53 expression with the clinicopathological features in tongue squamous cell carcinomas. Oral Oncol 35:56
99. Yin XY, Smith ML, Whiteside TL, Johnson JT, Herberman RS, Locker J (1993) Abnormalities in the p53 gene in rumors and cell lines of human squamous cell carcinomas of the head and neck. Int J Cancer 54:322